Martin Andrew Burian Buys 67,000 Shares of Nanalysis Scientific Corp. (CVE:NSCI) Stock

Nanalysis Scientific Corp. (CVE:NSCI) Director Martin Andrew Burian purchased 67,000 shares of the company’s stock in a transaction dated Wednesday, December 11th. The shares were acquired at an average price of C$0.28 per share, for a total transaction of C$18,760.00.

Nanalysis Scientific Trading Down 3.4 %

Shares of CVE:NSCI opened at C$0.28 on Friday. The company has a current ratio of 1.42, a quick ratio of 1.11 and a debt-to-equity ratio of 71.72. The stock has a market capitalization of C$31.66 million, a PE ratio of -2.33 and a beta of 0.72. Nanalysis Scientific Corp. has a 1 year low of C$0.26 and a 1 year high of C$0.60. The firm has a fifty day moving average price of C$0.35 and a 200 day moving average price of C$0.39.

Nanalysis Scientific Company Profile

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.